pimavanserin tartrate
ACP-103-020
Phase 3 small_molecule completed
Quick answer
pimavanserin tartrate for Parkinson's Disease Psychosis is a Phase 3 program (small_molecule) at Acadia Pharmaceuticals B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Acadia Pharmaceuticals B.V.
- Indication
- Parkinson's Disease Psychosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed